该产品被引用文献
Hypoglycaemia leads to a delayed increase in platelet and coagulation activation markers in people with type 2 diabetes treated with metformin only: Results from a stepwise hypoglycaemic clamp study. Aberer, F., Pferschy, P.N., Tripolt, N.J., Sourij, C., Obermayer, A.M., Prüller, F., Novak, E., Reitbauer, P., Kojzar, H., Prietl, B., Kofler, S., Brunner, M., Svehlikova, E., Stojakovic, T., Scharnagl, H., Oulhaj, A., Aziz, F., Riedl, R., Sourij, H., 2020. Diabetes, Obesity and Metabolism 22, 212–221.
Sandwich ELISA for the Quantification of Soluble Human Semaphorin 4D, a factor promoting skeletal metastases. Bitzer, A., Laber, A., Gadermaier, E., Wallwitz, J., Berg, G., Himmler, G., 2019, in: Osteologie. Presented at the OSTEOLOGIE 2019, Georg Thieme Verlag KG, p. V 1.8.
Plasma levels of Semaphorin 4D are decreased by adjuvant tamoxifen but not aromatase inhibitor therapy in breast cancer patients.
Göbel, A., Kuhlmann, J.D., Link, T., Wimberger, P., Link-Rachner, C., Thiele, S., Dell’Endice, S., Furesi, G., Breining, D., Rauner, M., Hofbauer, L.C., Rachner, T.D., 2019. Journal of Bone Oncology, 16: 100237. PMID: 31011525
A high-sensitivity enzyme immunoassay for the quantification of soluble human semaphorin 4D in plasma.
Laber, A., Gadermaier, E., Wallwitz, J., Berg, G., Himmler, G., 2019. Anal. Biochem. 574, 15–22.
PMID: 30879960